These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21529951)

  • 1. Complement factor I in health and disease.
    Nilsson SC; Sim RB; Lea SM; Fremeaux-Bacchi V; Blom AM
    Mol Immunol; 2011 Aug; 48(14):1611-20. PubMed ID: 21529951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation.
    Nilsson SC; Karpman D; Vaziri-Sani F; Kristoffersson AC; Salomon R; Provot F; Fremeaux-Bacchi V; Trouw LA; Blom AM
    Mol Immunol; 2007 Mar; 44(8):1835-44. PubMed ID: 17084897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible arrangement of the five domains in human complement factor I as determined by a combination of X-ray and neutron scattering and homology modeling.
    Chamberlain D; Ullman CG; Perkins SJ
    Biochemistry; 1998 Oct; 37(40):13918-29. PubMed ID: 9760226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of two novel cases of complete complement inhibitor Factor I deficiency.
    Nita IM; Genel F; Nilsson SC; Smart J; Truedsson L; Choo S; Blom AM
    Mol Immunol; 2011 Apr; 48(8):1068-72. PubMed ID: 21316765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in complement factor I as found in atypical hemolytic uremic syndrome lead to either altered secretion or altered function of factor I.
    Nilsson SC; Kalchishkova N; Trouw LA; Fremeaux-Bacchi V; Villoutreix BO; Blom AM
    Eur J Immunol; 2010 Jan; 40(1):172-85. PubMed ID: 19877009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of binding sites on complement factor I that are required for its activity.
    Nilsson SC; Nita I; Månsson L; Groeneveld TW; Trouw LA; Villoutreix BO; Blom AM
    J Biol Chem; 2010 Feb; 285(9):6235-45. PubMed ID: 20044478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of binding sites on complement factor I using artificial N-linked glycosylation.
    Sanchez-Gallego JI; Groeneveld TW; Krentz S; Nilsson SC; Villoutreix BO; Blom AM
    J Biol Chem; 2012 Apr; 287(17):13572-83. PubMed ID: 22393059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic, molecular and functional analyses of complement factor I deficiency.
    Nilsson SC; Trouw LA; Renault N; Miteva MA; Genel F; Zelazko M; Marquart H; Muller K; Sjöholm AG; Truedsson L; Villoutreix BO; Blom AM
    Eur J Immunol; 2009 Jan; 39(1):310-23. PubMed ID: 19065647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of defective complement control in hemolytic uremic syndrome.
    Zipfel PF; Misselwitz J; Licht C; Skerka C
    Semin Thromb Hemost; 2006 Mar; 32(2):146-54. PubMed ID: 16575689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The catalytically active serine protease domain of human complement factor I.
    Tsiftsoglou SA; Willis AC; Li P; Chen X; Mitchell DA; Rao Z; Sim RB
    Biochemistry; 2005 Apr; 44(16):6239-49. PubMed ID: 15835912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interactive Factor H-atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models.
    Saunders RE; Abarrategui-Garrido C; Frémeaux-Bacchi V; Goicoechea de Jorge E; Goodship TH; López Trascasa M; Noris M; Ponce Castro IM; Remuzzi G; Rodríguez de Córdoba S; Sánchez-Corral P; Skerka C; Zipfel PF; Perkins SJ
    Hum Mutat; 2007 Mar; 28(3):222-34. PubMed ID: 17089378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in complement factor I predispose to development of atypical hemolytic uremic syndrome.
    Kavanagh D; Kemp EJ; Mayland E; Winney RJ; Duffield JS; Warwick G; Richards A; Ward R; Goodship JA; Goodship TH
    J Am Soc Nephrol; 2005 Jul; 16(7):2150-5. PubMed ID: 15917334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization and expression analysis of the complement factor I (CpFI) in the whitespotted bamboo shark (Chiloscyllium plagiosum).
    Wang Y; Chen B; Ke Y; Wang C; Ye B
    Fish Shellfish Immunol; 2014 Oct; 40(2):414-23. PubMed ID: 25108086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome.
    Richards A; Kathryn Liszewski M; Kavanagh D; Fang CJ; Moulton E; Fremeaux-Bacchi V; Remuzzi G; Noris M; Goodship TH; Atkinson JP
    Mol Immunol; 2007 Jan; 44(1-3):111-22. PubMed ID: 16882452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies in haemolytic uraemic syndrome (HUS).
    Skerka C; Józsi M; Zipfel PF; Dragon-Durey MA; Fremeaux-Bacchi V
    Thromb Haemost; 2009 Feb; 101(2):227-32. PubMed ID: 19190803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of mutations in complement factor I (CFI) associated with hemolytic uremic syndrome.
    Kavanagh D; Richards A; Noris M; Hauhart R; Liszewski MK; Karpman D; Goodship JA; Fremeaux-Bacchi V; Remuzzi G; Goodship TH; Atkinson JP
    Mol Immunol; 2008 Jan; 45(1):95-105. PubMed ID: 17597211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for complement factor I control and its disease-associated sequence polymorphisms.
    Roversi P; Johnson S; Caesar JJ; McLean F; Leath KJ; Tsiftsoglou SA; Morgan BP; Harris CL; Sim RB; Lea SM
    Proc Natl Acad Sci U S A; 2011 Aug; 108(31):12839-44. PubMed ID: 21768352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in atypical hemolytic uremic syndrome provide evidence for the role of calcium in complement factor I.
    Java A; Atkinson J; Hu Z; Pozzi N
    Blood; 2023 Aug; 142(6):607-610. PubMed ID: 37363824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical haemolytic uraemic syndrome.
    Kavanagh D; Goodship TH; Richards A
    Br Med Bull; 2006; 77-78():5-22. PubMed ID: 16968692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquisition of complement inhibitor serine protease factor I and its cofactors C4b-binding protein and factor H by Prevotella intermedia.
    Malm S; Jusko M; Eick S; Potempa J; Riesbeck K; Blom AM
    PLoS One; 2012; 7(4):e34852. PubMed ID: 22514678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.